HER2 Support Group Forums - View Single Post

astrid · 11-21-2006, 09:35 AM

As you are node negative you may want to consider the clinical study CALGB 40101

www.cancer.gov/clinicaltrials/view_clinicaltrials.aspx?version=healthprofessiona l&cdrid=69444

<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com

ffice

ffice" /><o

></o

>

Standard chemo treatment is 4 rounds of doxorubicin (Adriamycin - A) with cyclophosphamide (Cytoxan - C), and 4 rounds of Paclitaxel (Taxol) T. So, this clinic study wants to see if node negative women who do not need aggressive chemo treatments will do better with A or T as dose dense standalone chemo treatments for 4 or 6 rounds.

11-21-2006, 09:35 AM	#8
astrid Senior Member Join Date: Jun 2006 Location: Central North Carolina, USA Posts: 112	As you are node negative you may want to consider the clinical study CALGB 40101 www.cancer.gov/clinicaltrials/view_clinicaltrials.aspx?version=healthprofessiona l&cdrid=69444 <?xml:namespace prefix = o ns = "urn:schemas-microsoft-comfficeffice" /><o></o> Standard chemo treatment is 4 rounds of doxorubicin (Adriamycin - A) with cyclophosphamide (Cytoxan - C), and 4 rounds of Paclitaxel (Taxol) T. So, this clinic study wants to see if node negative women who do not need aggressive chemo treatments will do better with A or T as dose dense standalone chemo treatments for 4 or 6 rounds. __________________ DX 11/14/05, Stage 1C, Her2+ 3.4, ER+, PR+, K167 23%, Node Negative, MX0, Grade 3, 1.8CM, Lumpectomy 12/7/05; 6 rounds dense dose Taxol bi-weekly, 35 radiation, 1 year Herceptin, & Tamoxifen ongoing.